Other than the CCDC6-RET fusion, which is expected to generate an oncogenic driver, it is difficult in most cases to predict the function of a given mutation (i.e. gain in oncogenic activity or a loss of tumor suppressor activity, or neither). This evidence concerns the gene RET and neoplasm.